Compugen Ltd (NASDAQ: CGEN) closed the day trading at $2.78 down -5.44% from the previous closing price of $2.94. In other words, the price has decreased by -$0.1600 from its previous closing price. On the day, 756581 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of CGEN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.36 and its Current Ratio is at 4.36. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On May 13, 2020, Stifel started tracking the stock assigning a Buy rating and target price of $19.Stifel initiated its Buy rating on May 13, 2020, with a $19 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEN now has a Market Capitalization of 219.41M and an Enterprise Value of 170.08M. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.44 while its Price-to-Book (P/B) ratio in mrq is 3.78. Its current Enterprise Value per Revenue stands at 5.08 whereas that against EBITDA is -13.59.
Stock Price History:
Over the past 52 weeks, CGEN has reached a high of $3.03, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 2.2078, while the 200-Day Moving Average is calculated to be 1.3004.
Shares Statistics:
Over the past 3-months, CGEN traded about 2.96M shares per day on average, while over the past 10 days, CGEN traded about 1.27M shares per day. A total of 89.24M shares are outstanding, with a floating share count of 84.65M. Insiders hold about 5.45% of the company’s shares, while institutions hold 13.60% stake in the company. Shares short for CGEN as of Feb 15, 2024 were 2.02M with a Short Ratio of 0.68, compared to 1.6M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.29% and a Short% of Float of 2.29%.
Earnings Estimates
Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.02 for the current quarter, with a high estimate of $0.07 and a low estimate of -$0.11, while EPS last year was -$0.11. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.05 and low estimates of -$0.11.
Analysts are recommending an EPS of between $0.26 and -$0.17 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$0.29, with 3 analysts recommending between -$0.09 and -$0.45.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for CGEN’s current fiscal year. The highest revenue estimate was $40M, while the lowest revenue estimate was $35.8M, resulting in an average revenue estimate of $38.6M. In the same quarter a year ago, actual revenue was $33.46M, up 15.40% from the average estimate.
